Cited by 330Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsPharmaceutical Practices and Patient Outcomes

Treatment of agitation in AD: A randomized, placebo-controlled clinical trial

Teri, L., Logsdon, R.G., Peskind, E., Raskind, M., Weiner, M.F., Tractenberg, R.E., Foster, N.L., Schneider, L.S. +9 more·2000·Neurology

Abstract

BACKGROUND: Treatment of agitation is a crucial problem in the care of patients with AD. Although antipsychotic and antidepressant medications and behavior management techniques (BMT) have each been used to treat agitation, clinical trials of these treatments have been characterized by small sample sizes and uncontrolled treatment designs. OBJECTIVE: To compare haloperidol, trazodone, and BMT with placebo in the treatment of agitation in AD outpatients. METHODS: A total of 149 patients with AD and their caregivers participated in a randomized, placebo-controlled, multicenter trial. Blind assessment was conducted at baseline and after 16 weeks of treatment. The three active treatments were haloperidol, trazodone, and BMT. The Alzheimer's Disease Cooperative Study Clinical Global Impression of Change was the primary outcome measure. Secondary outcomes included patient agitation, cognition, and function, and caregiver burden. RESULTS: Thirty-four percent of subjects improved relative to baseline. No significant differences on outcome were obtained between haloperidol (mean dose, 1.8 mg/d), trazodone (mean dose, 200 mg/d), BMT, or placebo. Significantly fewer adverse events of bradykinesia and parkinsonian gait were evident in the BMT arm. No other significant difference in adverse events was seen. Symptoms did not respond differentially to the different treatments. CONCLUSIONS: Comparable modest reductions in agitation occurred in patients receiving haloperidol, trazodone, BMT, and placebo. More effective pharmacologic, nonpharmacologic, and combination treatments are needed.

Integrity signals

Registry

Crossref · 10.1212/wnl.55.9.1271

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Teri, L., Logsdon, R. G., Peskind, E., Raskind, M., Weiner, M. F., Tractenberg, R. E., Foster, N. L., Schneider, L. S., Sano, M., Whitehouse, P., Tariot, P., Mellow, A. M., Auchus, A. P., Grundman, M., Thomas, R. G., Schafer, K., & Thal, L. J.
Affiliations
University of Southern California (US)
Venue
Neurology
Published
2000-11-14
Volume
55
Issue
9
Pages
1271-1278
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W1990805071
Cited by
330
References
36
Citations by year
2026: 6 · 2025: 8 · 2024: 7 · 2023: 2 · 2022: 34 · 2021: 12 · 2020: 7 · 2019: 7 · 2018: 8 · 2017: 4 · 2016: 12 · 2015: 11 · 2014: 11 · 2013: 8 · 2012: 11
FWCI
11.70
Type
journal article
Language
en
Open access
closed
Locations
  • Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Aging (AG 010483, U19AG010483)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
Alzheimer's disease, agitation, haloperidol, trazodone, behavior management strategies, antipsychotic drugs, antidepressants, caregiver burden, bradykinesia, parkinsonian gait, non-pharmacological treatment, outpatients
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Behavior Therapy, Double-Blind Method, Female, Haloperidol, Humans, Male, Psychomotor Agitation, Trazodone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review